Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Barchart

‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients

The Guardian - UK

How to ensure girls stay in STEM

Sexism in science and tech persists. We must do more to tackle it

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Robotics Stocks Powering the Automation Revolution

Robotics is pivotal in the automation revolution, driving substantial growth in diverse sectors like air defense and healthcare. Therefore, it could be wise to consider fundamentally strong robotics stocks like RTX (RTX), Stryker (SYK), and Medtronic (MDT). Read on.

StockNews.com

Abbott's Quarterly Earnings Preview: What You Need to Know

Abbott is all set to release its third-quarter earnings later this month, and analysts expect a single-digit profit increase.

Barchart

'Virus Hunters' Track Threats To Head Off Next Pandemic

A global network of doctors and laboratories is working to pinpoint emerging viral threats, including many driven by climate change, in a bid to head off the world's next pandemic.

International Business Times

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

StockNews.com

3 Recession-Proof Dividend Kings to Buy For a Lifetime of Income

Discover three proven, quality companies you can own to get through a looming recession.

Barchart

Is Abbott Stock Underperforming the S&P 500?

Abbott's shares have underperformed the broader S&P 500 this year, but analysts are highly bullish on the stock's potential.

Barchart

3 Robotics Stocks to Watch for the Automation Revolution

The robotics industry’s long-term growth is fueled by rapid technological advancements and automation across several sectors. Thus, it could be wise to keep an eye on fundamentally solid robotics stocks Stryker (SYK), Honeywell International (HON), and Medtronic (MDT) to capitalize on the automation revolution. Keep reading….

StockNews.com

3 Stocks Benefiting From the AI Boom—but Not Tech Companies

Artificial intelligence (AI) has been creating ripple effects across non-tech industries with new avenues for growth and innovation. With that in mind, let’s not miss out on investing in quality stocks from different sectors: Costco Wholesale Corp. (COST), Medtronic (MDT), and Korn Ferry (KFY), which are capitalizing on the AI…

StockNews.com

3 Dividend Kings With Massive Dividend Growth Rates

Learn how these three dividend kings can boost your portfolio's income potential.

Barchart

Nervous About the Market? 3 Defensive Stock Picks to Consider This August

Explore three defensive stock picks from the consumer staples, healthcare, and utilities sectors that offer stability amid market uncertainty in August.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Abbott Warns Of Potential Inaccuracies In Blood Sugar Monitoring Sensors

Abbott issues warning about potential inaccuracies in FreeStyle Libre 3 blood sugar sensors, offering free replacements for affected devices.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Abbott warns that some of its blood sugar monitors may need replacement due to incorrect readings

Abbott is warning that sensors on some of its blood sugar monitoring systems may need to be replaced to prevent inaccurate readings

Barchart

3 Highest-yielding Dividend Aristocrats With Strong-buy Ratings

Discover the top three highest-rated, highest-yielding Dividend Aristocrats for your retirement portfolio.

Barchart

Abbott's Q2 2024 Earnings: What to Expect

Abbott is poised to release its second-quarter results this month, and analysts are projecting a slight increase in profits.

StockNews.com

3 Top S&P 500 Stocks With Strong Analyst Ratings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The Independent UK

FDA took months to react to complaint about Abbott infant formula factory, audit finds

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

Barchart

How Is Abbott's Stock Performance Compared to Other Medical Devices Stocks?

Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

Evening Standard

Volatility halts hit numerous NYSE-listed stocks in error

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open in about a dozen companies, including Chipotle Mexican Grill Inc. and Abbott Laboratories.

1 … 4 5 6 7

People

Steven Abrams

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.